The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Microbiome, socioeconomic status (SES), fiber intake, and response to checkpoint inhibitor therapy in patients with non-small cell lung cancer (NSCLC): A pilot study.
 
Monaliben Patel
No Relationships to Disclose
 
Gurkan Bebek
No Relationships to Disclose
 
Brandon Vu
No Relationships to Disclose
 
Mahmoud Ghannoum
No Relationships to Disclose
 
Nathan A. Berger
No Relationships to Disclose
 
Debora S. Bruno
Honoraria - AstraZeneca
Consulting or Advisory Role - Amgen; AstraZeneca (I); Bristol Meyers Squibb; Daiichi Sankyo/Astra Zeneca; Lilly; Mirati Therapeutics; Novartis; Syneos Health
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb Foundation (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Dragonfly Therapeutics (Inst); Genentech (Inst); Mirati Therapeutics (Inst); Seagen (Inst)